ENTITY

Opexa Therapeutics (OPXA US)

Health Care • United States

Acer Therapeutics Inc. operates as a pharmaceutical company. The Company develops therapies for the treatment of ultra-rare diseases, vascular ehlers-danlos syndrome, and maple syrup urine diseases. Acer Therapeutics serves patients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00